Inactive Instrument

All News ASLAN Pharmaceuticals Limited Taipei Exchange

Equities

6497

KYG054241099

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

ASLAN Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05	CI
ASLAN Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update	09/05	AQ
Asian Equities Traded in the US as American Depositary Receipts Trend Slightly Lower in Wednesday Trading	08/05	MT
Asian Equities Traded in the US as American Depositary Receipts Drop Sharply in Tuesday Trading	07/05	MT
ASLAN Pharmaceuticals to Present Additional Data From Interim Analysis of TREK-DX Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients During Virtual KOL Event	07/05	AQ
Aslan Pharmaceuticals to Present Additional Data from Interim Analysis of Trek-DX Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients During Virtual KOL Event	07/05	CI
Tech Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Slightly Higher in Monday Trading	06/05	MT
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Friday Trading, End Week Over 2% Higher	03/05	MT
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading	02/05	MT
ASLAN Pharmaceuticals Announces Expansion of its Collaboration With Zenyaku to Investigate the Biology Underlying Differential Effects of Eblasakimab Compared to Other Biologics	02/05	AQ
ASLAN Pharmaceuticals Announces Expansion of its Collaboration with Zenyaku Kogyo Co., Ltd. to Investigate Biology Underlying Differential Effects of Eblasakimab Compared to Other Biologics	02/05	CI
Asian Equities Traded in the US as American Depositary Receipts Nudge Lower in Wednesday Trading	01/05	MT
ASLAN Pharmaceuticals to Host KOL Panel Discussion on Treatment Options for Atopic Dermatitis Patients With an Inadequate Response to Dupilumab	30/04	AQ
Asian Equities Traded in the US as American Depositary Receipts Open Week on Flat Note in Monday Trading	29/04	MT
Asian Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.5%	26/04	MT
Tech Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading	25/04	MT
ASLAN Pharmaceuticals Announces Late Breaking Abstract on Eblasakimab in COPD Accepted for Presentation at the American Thoracic Society International Conference	24/04	AQ
Technology Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading	23/04	MT
Asian Equities Traded in the US as American Depositary Receipts Open Week Higher	22/04	MT
ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice - April 19, 2024	22/04	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News ASLAN Pharmaceuticals Limited Taipei Exchange

Equities

6497

KYG054241099

All News

Filters